This inventor holds 11 USPTO granted patents and 3 published patent applications and 7 EPO patents. Top assignees: Novozymes A/s, Telefonaktiebolaget Lm Ericsson (Publ). Active years: 2017-2024.
Company Filing History:
Years Active: 2017-2024
Title: Vivek Srivastava: Innovator in Enzyme Technology
Introduction
Vivek Srivastava is a prominent inventor based in Bengaluru, India. He has made significant contributions to the field of enzyme technology, holding a total of 11 patents. His work focuses on developing innovative enzyme variants that have various applications in biotechnology.
Latest Patents
Among his latest patents are the "Mannanase variants and polynucleotides encoding same" and "Alpha-amylase variants and polynucleotides encoding same." The first invention relates to mannanase variants and includes polynucleotides encoding these variants, as well as nucleic acid constructs, vectors, and host cells that comprise the polynucleotides. The second invention focuses on alpha-amylase variants, similarly detailing the polynucleotides encoding these variants and their applications.
Career Highlights
Vivek has worked with notable companies such as Novozymes A/S and Telefonaktiebolaget LM Ericsson (Publ). His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in enzyme technology.
Collaborations
Some of his coworkers include Sohel Dalal and Padmavathi Balumuri. Their collaborative efforts have further advanced the research and development of innovative enzyme solutions.
Conclusion
Vivek Srivastava is a key figure in the field of enzyme technology, with a strong portfolio of patents that reflect his innovative spirit and dedication to advancing biotechnology. His contributions continue to impact various industries, showcasing the importance of research and development in this field.